ImmuCell Corporation
ICCC
$6.20
-$0.05-0.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 501.90K | 1.45M | 514.60K | -701.70K | -1.53M |
| Total Depreciation and Amortization | 668.20K | 676.00K | 673.80K | 675.10K | 671.00K |
| Total Amortization of Deferred Charges | 10.80K | 10.80K | 10.80K | 10.80K | 10.80K |
| Total Other Non-Cash Items | 20.80K | 19.10K | 32.30K | 40.10K | 75.10K |
| Change in Net Operating Assets | 399.80K | -579.00K | -1.23M | -663.70K | 1.36M |
| Cash from Operations | 1.60M | 1.57M | -3.10K | -639.30K | 581.80K |
| Capital Expenditure | -155.20K | -329.10K | -196.20K | -88.40K | -110.70K |
| Sale of Property, Plant, and Equipment | 29.20K | -- | 0.00 | 0.00 | 4.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -125.90K | -329.10K | -196.20K | -88.40K | -106.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -381.40K | -380.10K | -374.20K | -368.30K | -364.40K |
| Issuance of Common Stock | 329.90K | 19.40K | 814.90K | 3.58M | 417.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.90K | -43.00K | -291.80K | 0.00 | -164.80K |
| Cash from Financing | -76.40K | -403.60K | 148.90K | 3.21M | -111.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.40M | 841.10K | -50.40K | 2.48M | 363.90K |